期刊文献+

肿瘤受体显像剂^(99)Tc^m-octreotide的放化纯度分析 被引量:2

The Analytical of Radiochemical Purity of Tumor Receptor Imaging Agent ^(99)Tc^m-octreotide
下载PDF
导出
摘要 采用高压液相色谱分析(HPLC)和双层析结合银染色两种方法,对新型肿瘤受体显像剂^(99)Tc^m-oc-treotide的放化纯度进行分析。结果表明,双层析法结合银染色可以准确、有效地分离^(99)Tc^m-octreotide及其它放射性组分,可以较精确地计算出显像剂的放化纯度。为Octreotide及其它多肽类显像剂的放化纯度测定提供了一种简捷、准确的新手段。 The radiochemical purity of tumor receptor imaging agent 99Tcm-octreotide is measured by High Pressure Liquid Chromatography (HPLC) and two systems of chromatography combining method of silver stain. The results show that the radiochemical purity of 99Tcm-octreotide measured by both methods are effective and correct. It can separate 99Tcm-octreotide from other radioactive compositions correctly and effectively.
出处 《同位素》 CAS 2003年第1期26-29,共4页 Journal of Isotopes
关键词 肿瘤受体显像剂 放化纯度分析 高压液相色谱分析 银染色 双层析 奥曲肽 肿瘤定位 99Tcm-octreotide radiochemical purity two systems of chromatography silver stain high pressure liquid chromatography
  • 相关文献

参考文献4

  • 1武鸿文,管昌田,梁正路,李云春.肿瘤生长抑素受体显像剂^(99)Tc^m-octreotide的制备及鉴定[J].中华核医学杂志,2000,20(3):112-116. 被引量:16
  • 2Balon HR,Goldsmith ST,Siegel BA,et al. Procedure Guideline for Somatostatin Receptor Scintigraphy With 111In-Pentetrotide[J]. J Nucl Med,2001, 42:1134-1138.
  • 3Thakur ML, Kolan HR, John E, et al. Vapreotide With 99Tcm for Imaging Tumors: Preparation and Preliminary Evaluation[J]. Int J Oncl, 1996,9:445-451.
  • 4Bakker WH, Krenning EP, Breeman WA, et al.Receptor Scintigraphy With a Radioiodinated Somatostatin Analogue: Radiolabelling Purification,Biological Activity and in Vivo Application in Animals[J]. J Nucl Med,1990,31:1501-1509.

二级参考文献3

共引文献15

同被引文献49

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部